IGSLX
Price
$12.41
Change
+$0.07 (+0.57%)
Updated
Jul 3 closing price
Net Assets
2.13M
RPEBX
Price
$68.03
Change
+$0.38 (+0.56%)
Updated
Jul 3 closing price
Net Assets
156.22B
Interact to see
Advertisement

IGSLX vs RPEBX

Header iconIGSLX vs RPEBX Comparison
Open Charts IGSLX vs RPEBXBanner chart's image
Impax Global Social Leaders Investor
Price$12.41
Change+$0.07 (+0.57%)
VolumeN/A
Net Assets2.13M
American Funds New Perspective R2E
Price$68.03
Change+$0.38 (+0.56%)
VolumeN/A
Net Assets156.22B
IGSLX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 156B vs. IGSLX (2.13M). IGSLX pays higher dividends than RPEBX: IGSLX (0.67) vs RPEBX (0.12). IGSLX was incepted earlier than RPEBX: IGSLX (2 years) vs RPEBX (11 years). IGSLX (15.60) is less costly to investors than RPEBX (1.21). IGSLX is a more actively managed with annual turnover of: 30.00 vs. RPEBX (24.00). RPEBX has a lower initial minimum investment than IGSLX: RPEBX (250) vs IGSLX (1000). IGSLX annual gain was more profitable for investors over the last year : 13.84 vs. RPEBX (10.62).
IGSLXRPEBXIGSLX / RPEBX
Total Expense Ratio1.231.21102%
Annual Report Gross Expense Ratio15.601.211,289%
Fund Existence2 years11 years-
Gain YTD12.09112.68895%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.13M156B0%
Annual Yield % from dividends0.670.12542%
Returns for 1 year13.8410.62130%
Returns for 3 yearsN/A44.60-
Returns for 5 yearsN/A42.79-
Returns for 10 yearsN/A80.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCCP5.700.39
+7.34%
Cyclacel Pharmaceuticals
IRON54.751.58
+2.97%
Disc Medicine
IMUX0.730.01
+1.99%
Immunic
OPY67.771.20
+1.80%
Oppenheimer Holdings
MLI82.64-0.51
-0.61%
Mueller Industries